Published in Scand J Gastroenterol on January 01, 1981
Prognostic markers in acute pancreatitis: can pancreatic necrosis be predicted? Ann R Coll Surg Engl (1988) 1.52
Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks. Gut (1991) 0.92
Enzyme transfer from pancreas to plasma during acute pancreatitis. The contribution of ascitic fluid and lymphatic drainage of the pancreas. Gut (1985) 0.89
A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. Ann R Coll Surg Engl (1991) 0.83
Complement in Pancreatic Disease-Perpetrator or Savior? Front Immunol (2017) 0.75
The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem (1974) 2.65
Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci U S A (1986) 2.49
Combined analgesia and local anesthesia to minimize pain during circumcision. Arch Pediatr Adolesc Med (2000) 2.16
Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity. Rhinology (1979) 2.14
The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis (1977) 1.95
The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases. Eur J Biochem (1973) 1.92
Interaction between human or dog leucocyte proteases and plasma protease inhibitors. Scand J Clin Lab Invest (1971) 1.71
Increasing incidence of and declining mortality from breast carcinoma. Trends in Malmö, Sweden, 1961-1992. Cancer (1997) 1.70
The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med (1976) 1.57
Neutral leucocyte proteases and elastase inhibited by plasma alpha 1 -antitrypsin. Scand J Clin Lab Invest (1971) 1.50
Determination of immunoreactive trypsin, pancreatic elastase and chymotrypsin in extracts of human feces and ileostomy drainage. Digestion (1983) 1.37
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer (2003) 1.31
Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor. Biochim Biophys Acta (1982) 1.31
Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology (2002) 1.31
Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest (1976) 1.27
Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke (1996) 1.22
Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J (1991) 1.22
Elimination of 125-I-trypsin alpha-macroglobulin complexes from blood by reticuloendothelial cells in dogs. Acta Physiol Scand (1971) 1.22
Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest (1995) 1.20
Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis (1986) 1.19
Questionnaire versus direct technical measurements in assessing postures and movements of the head, upper back, arms and hands. Scand J Work Environ Health (2001) 1.14
Elevated serum levels of pancreatic secretory proteins in cigarette smokers after secretin stimulation. J Clin Invest (1980) 1.14
Demonstration and semiquantitative determination of complexes between various proteases and human alpha2-macroglobulin. Clin Chim Acta (1976) 1.14
Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretion. Hoppe Seylers Z Physiol Chem (1977) 1.13
Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors. Scand J Clin Lab Invest (1974) 1.13
Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum. Eur J Clin Invest (1975) 1.13
Alpha1-antitrypsin and alpha2-macroglobulin. Interactions with human neutrophil collagenase and elastase. Ann N Y Acad Sci (1975) 1.13
In vivo interaction beween trypsin and some plasma proteins in relation to tolerance to intravenous infusion of trypsin in dog. Acta Chir Scand (1971) 1.12
Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe Seylers Z Physiol Chem (1983) 1.11
Localization of chymotrypsin-like cationic protein, collagenase and elastase in azurophil granules of human neutrophilic polymorphonuclear leukocytes. Hoppe Seylers Z Physiol Chem (1977) 1.10
Distribution of antileukoprotease in upper respiratory mucosa. Ann Otol Rhinol Laryngol (1982) 1.09
Fractures of the scaphoid. Scand J Plast Reconstr Surg (1975) 1.07
Effects of granulocyte neutral proteases on complement components. Scand J Immunol (1976) 1.07
Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. J Matern Fetal Neonatal Med (2002) 1.06
Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis (1997) 1.05
Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis. Thromb Res (1986) 1.04
Release of proteolytic enzymes in bile-induced pancreatitis in dogs. Gastroenterology (1975) 1.04
Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol (1984) 1.04
Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches. Hoppe Seylers Z Physiol Chem (1977) 1.04
Experimental pancreatitis in the dog. Demonstration of trypsin in ascitic fluid, lymph and plasma. Scand J Gastroenterol (1973) 1.04
Immunoreactive granulocyte elastase in human serum. Hoppe Seylers Z Physiol Chem (1978) 1.03
Effect of education, occupation and some lifestyle factors on common rheumatic complaints in a Swedish group aged 50-70 years. Ann Rheum Dis (1992) 1.03
Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells. J Clin Pathol (1986) 1.03
Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia. Cerebrovasc Dis (2000) 1.01
Fish processing work: the impact of two sex dependent exposure profiles on musculoskeletal health. Occup Environ Med (1999) 1.01
Self-assessed and directly measured occupational physical activities--influence of musculoskeletal complaints, age and gender. Appl Ergon (2004) 1.00
The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation. Mediators Inflamm (2002) 1.00
alpha1-Antichymotrypsin interaction with cationic proteins from granulocytes. Clin Chim Acta (1976) 1.00
Sensitivity of trapezius electromyography to differences between work tasks - influence of gap definition and normalisation methods. J Electromyogr Kinesiol (2000) 0.99
Experimental pancreatitis in the dog. Appearance of complexes between proteases and trypsin inhibitors in ascitic fluid, lymph, and plasma. Scand J Gastroenterol (1971) 0.98
Lightscanning versus mammography for the detection of breast cancer in screening and clinical practice. A Swedish multicenter study. Cancer (1990) 0.97
Questionnaire-based mechanical exposure indices for large population studies--reliability, internal consistency and predictive validity. Scand J Work Environ Health (2001) 0.97
Precision of measurements of physical workload during standardised manual handling. Part II: Inclinometry of head, upper back, neck and upper arms. J Electromyogr Kinesiol (2005) 0.97
Studies on the turnover of endogenous cathodal trypsinogen in man. Eur J Clin Invest (1978) 0.96
Lidocaine-prilocaine cream for analgesia during circumcision in newborn boys. Cochrane Database Syst Rev (2000) 0.96
Localization of antileukoprotease in the parotid and the submandibular salivary glands. Acta Otolaryngol (1984) 0.94
Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables. Eur Respir J (1988) 0.94
Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukaemia. Scand J Haematol (1979) 0.94
The contents of macromolecule solutes in flexor tendon sheath fluid and their relation to synovial fluid. A quantitative analysis. J Hand Surg Br (1992) 0.94
The flare-up reactions after systemic provocation in contact allergy to nickel and gold. Contact Dermatitis (1999) 0.94
Validity of self-assessed reports of occurrence and duration of occupational tasks. Ergonomics (2005) 0.93
Isolation and some properties of a new enzyme-binding protein in rat plasma. Hoppe Seylers Z Physiol Chem (1978) 0.93
Distribution and elimination of intravenously injected urinary trypsin inhibitor. Scand J Clin Lab Invest (1991) 0.93
Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia. Cerebrovasc Dis (1998) 0.93
Purification and immunochemical quantitation of human pancreatic secretory trypsin inhibitor. Scand J Clin Lab Invest (1978) 0.93
Quantitation of active pancreatic endopeptidases in the intestinal contents of germfree and conventional rats. Scand J Gastroenterol (1976) 0.92
Demonstration of pancreatic protease-antiprotease complexes in the peritoneal fluid of patients with acute pancreatitis. Surgery (1979) 0.92
Anomalous distal branching of the median nerve. Case reports. Scand J Plast Reconstr Surg (1971) 0.91
Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures. Scand J Gastroenterol (1986) 0.91
Granular cell tumour of the mammary gland simulating malignancy. A report on two cases with light microscopy, transmission electron microscopy and immunohistochemical investigation. Virchows Arch A Pathol Anat Histopathol (1984) 0.91
The composition of catheter encrustations, including the effects of allopurinol treatment. Br J Urol (1984) 0.91
Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest (1992) 0.91
The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis. Res Exp Med (Berl) (1983) 0.90
Inhibitors of acrosin and granulocyte proteinases from human genital tract secretions. Hoppe Seylers Z Physiol Chem (1976) 0.90
Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity. Inflammation (1989) 0.90
Concentration of trypsin inhibitors of different molecular size and of albumin and haptoglobin in blood and in lymph of various organs in the dog. Acta Physiol Scand (1970) 0.90
Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa. J Gastroenterol (1996) 0.90
The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes. Scand J Haematol (1977) 0.90
Radioimmunological determination and characterization of cathodal trypsin-like immunoreactivity in normal human plasma. Scand J Clin Lab Invest (1976) 0.90
Interactions between bovine -chymotrypsin and the protease inhibitors of human and dog serum in vitro. Scand J Clin Lab Invest (1971) 0.90
Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin. Hoppe Seylers Z Physiol Chem (1983) 0.90
Varying occurrence of gastroduodenal immunoreactive pancreatic secretory trypsin inhibitor. J Clin Pathol (1987) 0.89
Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease. Scand J Gastroenterol (1986) 0.89
In vivo interaction between -chymotrypsin and plasma proteins in the dog. Scand J Clin Lab Invest (1971) 0.89
A radioimmunoassay for measurement of human pancreatic secretory trypsin inhibitor in different body fluids. Hoppe Seylers Z Physiol Chem (1978) 0.89
Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man. Scand J Gastroenterol (1984) 0.89
Localization and quantitation of a low molecular weight proteinase inhibitor, antileukoprotease, in the human uterus. Hoppe Seylers Z Physiol Chem (1981) 0.89
Muscular rest and gap frequency as EMG measures of physical exposure: the impact of work tasks and individual related factors. Ergonomics (2000) 0.88
Peritoneal lavage in severe acute pancreatitis. Acta Chir Scand (1984) 0.88
Purification and partial characterization of human pancreatic elastase. Hoppe Seylers Z Physiol Chem (1976) 0.88
Distribution of the secretory leucocyte proteinase inhibitor in human articular cartilage. Biol Chem (1997) 0.87
Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells. Mediators Inflamm (1999) 0.87